Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 4Phase 3 2Phase 1/2 1

Status

Terminated 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 552Colorectal Neoplasms 246Neoplasms 232Prostatic Neoplasms 221Carcinoma, Non-Small-Cell Lung 196Stomach Neoplasms 153Leukemia, Myeloid, Acute 149Carcinoma, Hepatocellular 147Lung Neoplasms 137Rectal Neoplasms 135Multiple Myeloma 133Nasopharyngeal Carcinoma 112Colonic Neoplasms 106Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Lymphoma 85Uterine Cervical Neoplasms 83Pancreatic Neoplasms 82Lymphoma, Large B-Cell, Diffuse 79Ovarian Neoplasms 78Leukemia 78Head and Neck Neoplasms 77Esophageal Neoplasms 74Lymphoma, Follicular 72Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 65Recurrence 64Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 58Pain 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Adenocarcinoma of the Prostate × Clear all
NCT03535675 2023-05-22

Muscadine Plus (MPX) In Men With Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 3 Terminated
59 enrolled 9 charts
Genitourinary

Adenocarcinoma of the Prostate

NCT03327662 2021-01-06

CTC-STOP

Institute of Cancer Research, United Kingdom

Phase 3 Terminated
12 enrolled
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡